130 related articles for article (PubMed ID: 16969131)
1. Selective induction of necrotic cell death in cancer cells by beta-lapachone through activation of DNA damage response pathway.
Sun X; Li Y; Li W; Zhang B; Wang AJ; Sun J; Mikule K; Jiang Z; Li CJ
Cell Cycle; 2006 Sep; 5(17):2029-35. PubMed ID: 16969131
[TBL] [Abstract][Full Text] [Related]
2. β-Lapachone induces programmed necrosis through the RIP1-PARP-AIF-dependent pathway in human hepatocellular carcinoma SK-Hep1 cells.
Park EJ; Min KJ; Lee TJ; Yoo YH; Kim YS; Kwon TK
Cell Death Dis; 2014 May; 5(5):e1230. PubMed ID: 24832602
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of poly(ADP-ribose) polymerase activation attenuates beta-lapachone-induced necrotic cell death in human osteosarcoma cells.
Liu TJ; Lin SY; Chau YP
Toxicol Appl Pharmacol; 2002 Jul; 182(2):116-25. PubMed ID: 12140175
[TBL] [Abstract][Full Text] [Related]
4. An NQO1 substrate with potent antitumor activity that selectively kills by PARP1-induced programmed necrosis.
Huang X; Dong Y; Bey EA; Kilgore JA; Bair JS; Li LS; Patel M; Parkinson EI; Wang Y; Williams NS; Gao J; Hergenrother PJ; Boothman DA
Cancer Res; 2012 Jun; 72(12):3038-47. PubMed ID: 22532167
[TBL] [Abstract][Full Text] [Related]
5. Release of mitochondrial cytochrome C in both apoptosis and necrosis induced by beta-lapachone in human carcinoma cells.
Li YZ; Li CJ; Pinto AV; Pardee AB
Mol Med; 1999 Apr; 5(4):232-9. PubMed ID: 10448645
[TBL] [Abstract][Full Text] [Related]
6. An NQO1- and PARP-1-mediated cell death pathway induced in non-small-cell lung cancer cells by beta-lapachone.
Bey EA; Bentle MS; Reinicke KE; Dong Y; Yang CR; Girard L; Minna JD; Bornmann WG; Gao J; Boothman DA
Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11832-7. PubMed ID: 17609380
[TBL] [Abstract][Full Text] [Related]
7. Catalase abrogates β-lapachone-induced PARP1 hyperactivation-directed programmed necrosis in NQO1-positive breast cancers.
Bey EA; Reinicke KE; Srougi MC; Varnes M; Anderson VE; Pink JJ; Li LS; Patel M; Cao L; Moore Z; Rommel A; Boatman M; Lewis C; Euhus DM; Bornmann WG; Buchsbaum DJ; Spitz DR; Gao J; Boothman DA
Mol Cancer Ther; 2013 Oct; 12(10):2110-20. PubMed ID: 23883585
[TBL] [Abstract][Full Text] [Related]
8. DNA damage and cytotoxicity induced by beta-lapachone: relation to poly(ADP-ribose) polymerase inhibition.
Vanni A; Fiore M; De Salvia R; Cundari E; Ricordy R; Ceccarelli R; Degrassi F
Mutat Res; 1998 Jun; 401(1-2):55-63. PubMed ID: 9639674
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer radiosensitization through poly(ADP-Ribose) polymerase-1 hyperactivation.
Dong Y; Bey EA; Li LS; Kabbani W; Yan J; Xie XJ; Hsieh JT; Gao J; Boothman DA
Cancer Res; 2010 Oct; 70(20):8088-96. PubMed ID: 20940411
[TBL] [Abstract][Full Text] [Related]
10. Induction of CDK inhibitors (p21(WAF1) and p27(Kip1)) and Bak in the beta-lapachone-induced apoptosis of human prostate cancer cells.
Don MJ; Chang YH; Chen KK; Ho LK; Chau YP
Mol Pharmacol; 2001 Apr; 59(4):784-94. PubMed ID: 11259623
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of p53, induction of Bax and activation of caspases during beta-lapachone-mediated apoptosis in human prostate epithelial cells.
Choi YH; Kim MJ; Lee SY; Lee YN; Chi GY; Eom HS; Kim ND; Choi BT
Int J Oncol; 2002 Dec; 21(6):1293-9. PubMed ID: 12429980
[TBL] [Abstract][Full Text] [Related]
12. Preclinical genotoxicology of nor-β-lapachone in human cultured lymphocytes and Chinese hamster lung fibroblasts.
Cavalcanti BC; Barros FW; Cabral IO; Ferreira JR; Magalhães HI; Júnior HV; da Silva Júnior EN; de Abreu FC; Costa CO; Goulart MO; Moraes MO; Pessoa C
Chem Res Toxicol; 2011 Sep; 24(9):1560-74. PubMed ID: 21830773
[TBL] [Abstract][Full Text] [Related]
13. Nanosecond pulsed electric fields induce poly(ADP-ribose) formation and non-apoptotic cell death in HeLa S3 cells.
Morotomi-Yano K; Akiyama H; Yano K
Biochem Biophys Res Commun; 2013 Aug; 438(3):557-62. PubMed ID: 23899527
[TBL] [Abstract][Full Text] [Related]
14. Nonhomologous end joining is essential for cellular resistance to the novel antitumor agent, beta-lapachone.
Bentle MS; Reinicke KE; Dong Y; Bey EA; Boothman DA
Cancer Res; 2007 Jul; 67(14):6936-45. PubMed ID: 17638905
[TBL] [Abstract][Full Text] [Related]
15. Leveraging an NQO1 Bioactivatable Drug for Tumor-Selective Use of Poly(ADP-ribose) Polymerase Inhibitors.
Huang X; Motea EA; Moore ZR; Yao J; Dong Y; Chakrabarti G; Kilgore JA; Silvers MA; Patidar PL; Cholka A; Fattah F; Cha Y; Anderson GG; Kusko R; Peyton M; Yan J; Xie XJ; Sarode V; Williams NS; Minna JD; Beg M; Gerber DE; Bey EA; Boothman DA
Cancer Cell; 2016 Dec; 30(6):940-952. PubMed ID: 27960087
[TBL] [Abstract][Full Text] [Related]
16. PARP1-mediated necrosis is dependent on parallel JNK and Ca²⁺/calpain pathways.
Douglas DL; Baines CP
J Cell Sci; 2014 Oct; 127(Pt 19):4134-45. PubMed ID: 25052090
[TBL] [Abstract][Full Text] [Related]
17. Potent induction of apoptosis by beta-lapachone in human multiple myeloma cell lines and patient cells.
Li Y; Li CJ; Yu D; Pardee AB
Mol Med; 2000 Dec; 6(12):1008-15. PubMed ID: 11474117
[TBL] [Abstract][Full Text] [Related]
18. Yeast cytotoxic sensitivity to the antitumour agent β-lapachone depends mainly on oxidative stress and is largely independent of microtubule- or topoisomerase-mediated DNA damage.
Ramos-Pérez C; Lorenzo-Castrillejo I; Quevedo O; García-Luis J; Matos-Perdomo E; Medina-Coello C; Estévez-Braun A; Machín F
Biochem Pharmacol; 2014 Nov; 92(2):206-19. PubMed ID: 25241291
[TBL] [Abstract][Full Text] [Related]
19. The NQO1 bioactivatable drug, β-lapachone, alters the redox state of NQO1+ pancreatic cancer cells, causing perturbation in central carbon metabolism.
Silvers MA; Deja S; Singh N; Egnatchik RA; Sudderth J; Luo X; Beg MS; Burgess SC; DeBerardinis RJ; Boothman DA; Merritt ME
J Biol Chem; 2017 Nov; 292(44):18203-18216. PubMed ID: 28916726
[TBL] [Abstract][Full Text] [Related]
20. beta-lapachone, a novel plant product, overcomes drug resistance in human multiple myeloma cells.
Gupta D; Podar K; Tai YT; Lin B; Hideshima T; Akiyama M; LeBlanc R; Catley L; Mitsiades N; Mitsiades C; Chauhan D; Munshi NC; Anderson KC
Exp Hematol; 2002 Jul; 30(7):711-20. PubMed ID: 12135668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
